<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" specific-use="sps-1.8" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">rca</journal-id>
			<journal-title-group>
				<journal-title>Revista Colombiana de Anestesiología</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. colomb. anestesiol.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0120-3347</issn>
			<publisher>
				<publisher-name>SCARE-Sociedad Colombiana de Anestesiología y Reanimación</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.1097/CJ9.0000000000000009</article-id>
			<article-id pub-id-type="publisher-id">00009</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artículo de revisión</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Management of acute pain in extensive burn injury: Nonsystematic review of the literature</article-title>
				<trans-title-group xml:lang="es">
					<trans-title>Manejo del dolor agudo en el paciente gran quemado: Revisión no sistemática de la literatura</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Cáceres-Jerez</surname>
						<given-names>Luz Elena</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>a</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Gomezese-Ribero</surname>
						<given-names>Omar Fernando</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>b</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Reyes-Cárdenas</surname>
						<given-names>Laura Isabel</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>c</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Vera-Campos</surname>
						<given-names>Julián Andrés</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>d</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Guzmán-Rueda</surname>
						<given-names>Valentina Alejandra</given-names>
					</name>
					<xref ref-type="aff" rid="aff5"><sup>e</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Azar-Villalobos</surname>
						<given-names>Juan Pablo</given-names>
					</name>
					<xref ref-type="aff" rid="aff5_1"><sup>e</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Meléndez-Flórez</surname>
						<given-names>Héctor Julio</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>f</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>a</label>
				<institution content-type="original"> Pain and Palliative Care Clinic, Fundación Cardiovascular de Colombia, Floridablanca, Colombia</institution>
				<institution content-type="orgname">Fundación Cardiovascular de Colombia</institution>
				<addr-line>
					<named-content content-type="state">Floridablanca</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff2">
				<label>b</label>
				<institution content-type="original"> Pain and Palliative Care Clinic, Fundación Cardiovascular de Colombia, Anaesthesiology and Resuscitation Specialisation Course, Universidad Industrial de Santander, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff3">
				<label>c</label>
				<institution content-type="original"> Fundación Cardiovascular de Colombia, Floridablanca, Colombia</institution>
				<institution content-type="orgname">Fundación Cardiovascular de Colombia</institution>
				<addr-line>
					<named-content content-type="state">Floridablanca</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff4">
				<label>d</label>
				<institution content-type="original"> Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Autónoma de Bucaramanga</institution>
				<institution content-type="orgname">Universidad Autónoma de Bucaramanga</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff5">
				<label>e</label>
				<institution content-type="original"> Universidad Industrial de Santander, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff5_1">
				<label>e</label>
				<institution content-type="original"> Universidad Industrial de Santander, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff6">
				<label>f</label>
				<institution content-type="original"> Intensive Care Unit, Hospital Universitario de Santander, Anaesthesiology and Resuscitation Specialisation Course, Universidad Industrial de Santander, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label> </label><bold>Correspondence:</bold> Fundación Cardiovascular de Colombia, Calle 155 A No. 23-58, Urbanización El Bosque, Departamento de Neurociencias, Floridablanca 681004, Colombia. E-mail: investigaciondolorfcv@hotmail.com</corresp>
			</author-notes>
			<pub-date pub-type="epub-ppub">
				<season>Jan-Apr</season>
				<year>2018</year>
			</pub-date>
			<volume>46</volume>
			<issue>1</issue>
			<fpage>49</fpage>
			<lpage>54</lpage>
			<permissions>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Abstract</title>
				<sec>
					<title>Introduction: </title>
					<p>Management of acute pain is essential in the treatment of burned patients. Current pain management approaches focus on the control of the somatic component reflecting the insult. However, the injury comprises emotional, physical, and psychological components that require multi-disciplinary management, including pharmacological and nonpharmacological interventions to break the vicious circle of pain and its complications.</p>
				</sec>
				<sec>
					<title>Objective: </title>
					<p>To perform a nonsystematic review of the literature on the pharmacological and nonpharmacological management of pain in patients with extensive burns.</p>
				</sec>
				<sec>
					<title>Methods: </title>
					<p>Nonsystematic review of the literature published between 2000 and 2016 in MEDLINE/PubMed, Embase, Sciencedirect, SciELO, LILACS, Google Scholar, academic books, and institutional management guidelines.</p>
				</sec>
				<sec>
					<title>Results: </title>
					<p>After analyzing the literature, it was found that the management of acute pain in the patients with severe burn injury should be based on a multidisciplinary approach.</p>
				</sec>
				<sec>
					<title>Conclusions: </title>
					<p>Management of acute pain in patients with severe burn injury should not focus only on the somatic components of pain but should also encompass the emotional, physical, and psychosocial components, in order to provide comprehensive management, both pharmacological and nonpharmacological.</p>
				</sec>
			</abstract>
			<trans-abstract xml:lang="es">
				<title>Resumen</title>
				<sec>
					<title>Introducción: </title>
					<p>El manejo del dolor agudo es fundamental en el tratamiento de los pacientes quemados. Los esquemas actuales de manejo de dolor se enfocan en el control del componente somático que refleja la noxa, sin embargo es un evento con componentes emocionales, físico y psíquicos, que requiere manejo multidisciplinario incluyendo intervenciones farmacológicas y no farmacológicas, para romper el círculo vicioso del dolor y sus complicaciones.</p>
				</sec>
				<sec>
					<title>Objetivo: </title>
					<p>Realizar una revisión no sistemática de la literatura sobre el manejo farmacológico y no farmacológico del dolor agudo en el paciente gran quemado.</p>
				</sec>
				<sec>
					<title>Metodología: </title>
					<p>Se realizó una revisión no sistemática en MEDLINE/PubMed, Embase, Science Direct, SciELO, LILACS, Google Scholar, libros académicos, guías de manejo institucionales, desde el año 2000 hasta el 2016.</p>
				</sec>
				<sec>
					<title>Resultados: </title>
					<p>Luego de analizar la literatura se encuentra que el manejo del dolor agudo en el paciente gran quemado debe recibir un enfoque multidisciplinario.</p>
				</sec>
				<sec>
					<title>Conclusiones: </title>
					<p>El manejo agudo del dolor en el paciente gran quemado no se debe centrar solamente en los componentes somáticos del mismo, sino que debe extenderse a los componentes emocionales físicos y psicosociales, para brindar un manejo integral, tanto farmacológico como no farmacológico.</p>
				</sec>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>Pain</kwd>
				<kwd>Acute Pain</kwd>
				<kwd>Analgesics</kwd>
				<kwd>Burns</kwd>
				<kwd>Pain Management</kwd>
			</kwd-group>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Dolor</kwd>
				<kwd>Dolor Agudo</kwd>
				<kwd>Analgésico</kwd>
				<kwd>Quemaduras</kwd>
				<kwd>Manejo del Dolor</kwd>
			</kwd-group>
			<counts>
				<fig-count count="1"/>
				<table-count count="0"/>
				<equation-count count="0"/>
				<ref-count count="56"/>
				<page-count count="6"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>Introduction and objectives</title>
			<p>One of the fundamental pillars in the treatment of patients with acute burns is effective pain management, which also requires indirect early management of short-term complications derived from ineffectual management, including venous thrombosis, hypertension with target organ, tachycardia, coronary event, hyperglycemia, immunosuppression, as well as of the long-term complications such as neuropathic pain, depression, anxiety, and joint contractures.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>
			</p> <p>In the current literature, pain management approaches in patients with burn injuries focus on controlling the somatic component reflecting the traumatic insult. However, pain in burn injuries is much more complex, involving multiple areas (physical, emotional, psychological) and involving pathophysiological mechanisms that mean much more than just a phenomenon that can be addressed with the administration of opioids. Consequently, pain management must be based on the best available evidence and performed by a multidisciplinary team using pharmacological and nonpharmacological interventions<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> in order to break the vicious circle of pain and prevent the previously mentioned complications that may be triggered after a burn injury.</p>
			<p>All of the above created the need to conduct a nonsystematic review of the literature on the comprehensive management of acute pain in patients with severe burn injury, summarizing the most relevant findings, so as to apply them at Hospital Universitario de Santander, one of the few medical centers with a care unit for burn patients. This document was developed by Universidad Industrial de Santander and it is designed to provide guidelines for acute pain management in this patient population that can be applied at any point in the acute care process. Its application is not limited just to Level III or Level IV care institutions in our country.</p>
		</sec>
		<sec sec-type="methods">
			<title>Method</title>
			<p>A nonsystematic review of the literature between 2000 and 2016, from databases such as MEDLINE/PUBMED, Embase, Science Direct, SciELO, LILACS, and Google scholar databases, as well as in academic texts, institutional management guidelines or regulatory documents, using the following search terms in English and Spanish: acute pain, burns, analgesics, therapy, pathophysiology of burns, nonpharmacologic analgesic for acute burn pain, management of pain in burned children, virtual reality in burn pain, opioid withdrawal, opioid overdose, management of pruritus in burns, acute pain in burn patients, burn, analgesia, perioperative management in burn patients, pain management in the pediatric burn patient, opioid overdosing, opioid weaning, management of pruritus in burns. Meta-analyses, clinical trials, observational studies, review articles, case series, management guidelines, and books were considered, excluding those that did not contribute relevant information about acute management and those that were outside the search dates (<xref ref-type="fig" rid="f1">Figure 1</xref>). The authors read the retrieved articles and selected those cited in the references. The results of this review, from the perspective of the authors, are presented as follows.</p>
			<p>
				<fig id="f1">
					<label>Figure 1</label>
					<caption>
						<title>Search and selection flowchart.</title>
					</caption>
					<graphic xlink:href="0120-3347-rca-46-01-00049-gf1.png"/>
					<attrib>Source: Authors.</attrib>
				</fig>
			</p>
			<sec>
				<title><italic>Pain assessment</italic></title>
				<p>Pain assessment must be performed before, during, and after a painful procedure, and also 30 minutes after an analgesic intervention, and it must be objective and performed regularly using a validated tool<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> such as the following: Visual Analogue Scale (VAS), in patients over 8 years of age<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>; Verbal Numeric Scale (VNS), in patients over 12 years of age and in settings where there is limited understanding of the VAS<sup>8</sup>; Verbal Global Scale (VGS), in patients over 12 and in settings where there is limited understanding of the VAS and the VNS<sup>8</sup>; Smiles Pain Rating Scale (SRPS), in patients 5 to 12 years of age<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>; FLACC (pain facies, lower limb movements, agitation, consolabilty, and crying), in children under 5 years of age.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Pharmacological managementrgeneral</italic></title>
				<p>Potent opioid drugs are the cornerstone in the management of acute pain due to burn injuries.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref> It is suggested to initiate management with potent opioid drugs and then taper down, instead of scaling up in potency.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref> Every service in which these drugs are used routinely must have access to oxygen sources, devices, and trained staff for cardiopulmonary cerebral (CPCR) resuscitation, and naloxone.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref> In addition, side effects from opioid administration must be anticipated and treated aggressively.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref> Extremely painful procedures or procedures that cannot be tolerated by the patient must be performed under general anaesthesia.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Underlying pain management: paracetamol and nonsteoridal anti-inflammatory agents (NSAIDs)</italic></title>
				<p>It is advisable to give all patients a scheduled around-the-clock (ATC) prescription of paracetamol 500 mg p.o. every 6 hours in adults, and 10 to 15mg/kg every 6 hours in children<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref> as part of underlying pain management, unless contraindicated.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Adding an ATC short-cycle (maximum 3 days) prescription of nonsteoridal anti-inflammatory agents (NSAIDs) may be considered<xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref> (ibuprofen 400 mg Per Os (PO) every 8 hours, 10 mg/kg every 8hours in children over 6 months of age, or diclofenac 50 mg PO every 12hours, 75 mg IV every 12hours in adults, 1 to 2 mg/kg every 12 hours in children over 5 years of age), and ATC paracetamol in noncritically ill patients with preserved oral route during the acute burn phase.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Underlying pain management: opioids</italic></title>
				<p>Should pain control not be achieved with the administration of paracetamol or a short cycle of NSAIDs, a weak opioid agonist should be added ATC to the pharmacological regimen, including tramadol 1 mg/kg/dose every 6 to 8 hours in children or 50 to 100 mg Intravenous (IV) every 6 to 8hours maximum 400mg/day in adults, or codeine 1 mg/kg/dose every 6 to 8hours in children, or 30 to 60 mg PO every 6 hours in adults, maximum 240mg/day.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref>
				</p> <p>If these measures are not sufficient to achieve adequate pain control, pharmacological management with a scheduled strong opioid agonist should be initiated, making sure that the weak opioid administration is discontinued first, as follows: low-dose intravenous morphine titration (1-2 mg in adults, 0.01 mg/kg in children) every 5 to 10 minutes until pain control is achieved or until the patient is drowsy, titrating the whole dose every 4 to 6 hours if persistence of the cause of pain is anticipated.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
				</p> <p>If no strong opioid is available, ATC administration of an agonist-antagonist opioid-like nalbuphine 0.4mg/kg/dose every 4 to 6 hours may be prescribed instead of the weak opioid.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Incident pain management</italic></title>
				<p>Another management option for acute pain is patient-controlled analgesia (PCA), which is mainly useful for incident pain management. PCA with fentanyl is recommended using 1 initial bolus of 1 mg/kg, 30 mg on demand, with 5-minute closure interval, or intravenous morphine 0.05 to 0.2 mg/kg/dose every 4 to 6 hours.<sup>7</sup> Also useful in the management of incident pain is meperidine 1 mg/kg/dose (maximum 4 doses in total).<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Management of procedure-associated pain</italic></title>
				<p>There are several options with high-quality evidence for the management of pain caused by procedures in this population. The first is the application of a strong opioid before the procedure (morphine 0.05-0.2 mg/kg 10 minutes before, or fentanyl 1 mg/kg 5 minutes before) or the use of PCA associated with a benzodiazepine before the procedure (midazolam 0.05 mg/kg 30minutes-1hour be-fore).<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref> The association with ketamine has been used widely for more than 40 years in burn patients, but its use has diminished because of the side effects, which can be avoided when used together with a benzodiazepine. Ketamine at a dose of 1 mg/kg associated with a benzodiazepine (midazolam 0.05 mg/kg) and an antisia-lagogue (atropine 0.01mg/kg) is an excellent analgesic option, provided it is administered in centers where the anesthetist is present.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>
				</p> <p>Another combination of drugs that offers excellent analgesic effect for procedure-associated pain is dexmedetomidine in a 1 mg/kg bolus, associated with a bolus dose of ketamine 2 mg/kg and tramadol 1 mg/kg, in intermediate care facilities, with presence of staff trained in CPCR or of the anaesthetist.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref>
				</p> <p>On the contrary, nonpharmacological interventions in adolescents include the association of virtual reality, performed in facilities with the appropriate infrastructure and duly trained personnel,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref> as well as the use of transcutaneous electrical stimulation (TENS), before, during, and after the procedure. These interventions need to be explained to the patient and used in association with pharmacological regimens.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Postoperative pain management</italic></title>
				<p>The plastic surgery anesthesia service should think about using preventive systemic analgesia with NSAIDs or systemic paracetamol before the procedure,<xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref> and tumescent anaesthesia,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> regional blocks,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref> or topical lidocaine for dressing changes<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref> in an attempt at providing residual analgesic effect after the surgical-anesthetic procedure. In stable patients who tolerate well the oral route, the use of weak opioids can be considered, including codeine at a dose of 30 to 60 mg every 6hours and a maximum dose of 240mg/day, maintaining active vigilance on side effects in order to treat them promptly. The use of conventional oxycodone at a dose of 5 to 10 mg every 8 hours or with an extended release formula every 12 to 24hours, methadone 2.5 to 5mg every 6hours, or hydrocodone 5 to 10mg every 4 to 6hours may also be considered. It is important to try not to use oral opioids for more than 10 days in order to avoid physical dependence.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Neuropathic pain management</italic></title>
				<p>Given the characteristics of the injuries in burn patients, neuropathic pain is common in this population. Consequently, the early association of pregabalin is recommended on the basis of proven clinical effectiveness in reducing peripheral and central neuropathic pain at a starting titration of 37.5 mg with oral opioid.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B34"><sup>34</sup></xref> In situations where there is no access to pregabalin, the use of gabapentin should be considered, at an initial titration of 300mg PO per day.<xref ref-type="bibr" rid="B33"><sup>33</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B36"><sup>36</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Pruritus</italic></title>
				<p>Pruritus must be treated with pharmacological measures such as gabapentin in incremental doses, from 300 mg up to 1500mg/day PO<xref ref-type="bibr" rid="B37"><sup>37</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B42"><sup>42</sup></xref> and also with nonpharmacological measures proven to be effective,<xref ref-type="bibr" rid="B37"><sup>37</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref> bearing in mind that the oral route may be used for administering medications in cases of mild burns,<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref> and that the intramuscular and subcutaneous routes should not be used in the acute phase of the burn injury.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Nonpharmacological management</italic></title>
				<p>Nonpharmacological options should be offered together with pharmacological ones.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref> In services with the adequate facilities and trained personnel, nonpharmacological strategies may include music therapy, hypnosis, nonimmersive virtual reality (images, videos, video games) or immersive virtual reality, and psychotherapy before and after any procedure, and throughout the treatment period.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B44"><sup>44</sup></xref>
				</p> </sec>
		</sec>
		<sec>
			<title>Management of complications secondary to the use of medications for analgesic management in burn patients</title>
			<sec>
				<title><italic>Opioid-related respiratory depression</italic></title>
				<p>The use of opioids in high doses in patients with burn injuries entails the risk of secondary adverse events. The most serious of those adverse events is respiratory depression. Recognizing or suspecting this condition early on is mandatory when faced with a patient with a confirmed history of receiving high-dose opioids, a respiratory rate lower than 8/minute, myosis, pulse oximetry below 90%, and drowsiness or stupor. Response must be immediate, priority alert must be sent to the anesthesia and emergency services, and tactile and auditory stimulation of the patient must be initiated. Naloxone must also be titrated at a dose of 1 mg/kg IV every 3 to 5 minutes until bradypnea resolves or the patient shows signs of recovering consciousness and an arterial oxygen saturation of 91% or higher. The attending physician must determine if the patient needs basic and/or advanced airway management and ventilation in accordance with the CPCR guidelines, in which he/she must be trained. Attention must be paid to the possibility of renarcotization, depending on the opioid that caused the depression and the form of use.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B45"><sup>45</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B47"><sup>47</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Benzodiazepine-related respiratory depression</italic></title>
				<p>In case respiratory depression secondary to the use of benzodiazepines is suspected, the administration of flumazenil 0.2 mg IV every minute is recommended until the patient regains consciousness, followed by the steps described above under the heading on management of opioid-related respiratory depression.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B48"><sup>48</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B49"><sup>49</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Ketamine-related psychotomimetic crisis</italic></title>
				<p>In the event of altered sensory perception (hallucinations, delusions) or behavior (agitation, inattention) suspected to be related to the use of ketamine, the emergency anesthesia service should be notified immediately while simultaneously initiating midazolam at a dose of 0.05 mg/kg.<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B49"><sup>49</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B50"><sup>50</sup></xref>
				</p> </sec>
			<sec>
				<title><italic>Weaning from potent parenteral opioids in the step-down unit and the intensive care unit</italic></title>
				<p>Whenever an opioid withdrawal syndrome is suspected, active support from the Pain Clinic and the psychology and psychiatry services of the institution must be requested.</p>
				<p>Withdrawal syndrome in patients managed with strong opioids in the Burn Unit (step-down unit) or the Intensive Care Unit must be suspected in the presence of suggestive symptoms such as tachycardia, diaphoresis, hypertension, mydriasis, piloerection, muscle cramps, abdominal cramps, or diarrhea. Weaning from potent opioids is suggested if they have been used for more than 5 days, tapering the dose initially by 20% to 40%, followed by subsequent 10% reductions every 12 to 24hours.<xref ref-type="bibr" rid="B51"><sup>51</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B54"><sup>54</sup></xref>
				</p> <p>In the presence of physical findings of opioid withdrawal when strong opioids have been used for more than 10 days, the initiation of substitution therapy with metha-done at a fractionated equianalgesic dose every 6 to 8 hours can be considered, tapering it down by 20% every week until complete discontinuation is achieved towards the fifth week.<xref ref-type="bibr" rid="B51"><sup>51</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B55"><sup>55</sup></xref>
				</p> <p>The concomitant use of nonsubstitution therapy (ben-zodiazepines, clonidine) is suggested.<xref ref-type="bibr" rid="B54"><sup>54</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B56"><sup>56</sup></xref>
				</p> </sec>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusion</title>
			<p>Pain management in burn patients is a challenge given that, ideally, it requires a multidisciplinary approach. Understanding the pathophysiology of burn injuries is critical in order to understand the type and the severity of the pain that these patients may experience. Acute pain management should not focus only on the somatic components of pain but must also encompass the emotional and psychosocial components, in order to provide comprehensive management, both pharmacological and nonpharmacological.</p>
		</sec>
		<sec>
			<title>Ethical disclosures</title>
			<p><bold>Protection of human and animal subjects.</bold> The authors declare that no experiments were performed on humans or animals for this study.</p>
			<p><bold>Confidentiality of data.</bold> The authors declare that they have followed the protocols of their work center on the publication of patient data.</p>
			<p><bold>Right to privacy and informed consent.</bold> The authors declare that no patient data appear in this article.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Browne A, Andrews R, Schug S, et al. Persistent pain outcomes and patient satisfaction with pain management after burn injuries. Clin J Pain 2011; 27:136-145.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Browne</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Andrews</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Schug</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Persistent pain outcomes and patient satisfaction with pain management after burn injuries</article-title>
					<source>Clin J Pain</source>
					<year>2011</year>
					<volume>27</volume>
					<fpage>136</fpage>
					<lpage>145</lpage>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Ramírez C, Ramírez C, González L, et al. Fisiopatología del paciente quemado. Reu Salud UIS 2010; 42:55-65.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ramírez</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Ramírez</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>González</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Fisiopatología del paciente quemado</article-title>
					<source>Reu Salud UIS</source>
					<year>2010</year>
					<volume>42</volume>
					<fpage>55</fpage>
					<lpage>65</lpage>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Dauber A, Osgood P, Breslau A, et al. Chronic persistent pain after severe burns: a survey of 358 burn survivors. Pain Med 2002; 3:6-17.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dauber</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Osgood</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Breslau</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Chronic persistent pain after severe burns a survey of 358 burn survivors</article-title>
					<source>Pain Med</source>
					<year>2002</year>
					<volume>3</volume>
					<fpage>6</fpage>
					<lpage>17</lpage>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Dyster-Aas J, Willebrand M, Wikehult B, et al. Major depression and posttraumatic stress disorder symptoms following severe burn injury in relation to lifetime psychiatric morbidity. J Trauma 2008; 64:1349-1356.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dyster-Aas</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Willebrand</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Wikehult</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Major depression and posttraumatic stress disorder symptoms following severe burn injury in relation to lifetime psychiatric morbidity</article-title>
					<source>J Trauma</source>
					<year>2008</year>
					<volume>64</volume>
					<fpage>1349</fpage>
					<lpage>1356</lpage>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Patterson D, TininenkoJ, PtacekJ. Pain during burn hospitalization predicts long term outcome. J Burn Care Res 2006; 27:719-726.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Patterson</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>TininenkoJ</surname>
							<given-names/>
						</name>
						<name>
							<surname>PtacekJ</surname>
							<given-names/>
						</name>
					</person-group>
					<article-title>Pain during burn hospitalization predicts long term outcome</article-title>
					<source>J Burn Care Res</source>
					<year>2006</year>
					<volume>27</volume>
					<fpage>719</fpage>
					<lpage>726</lpage>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Faucher L, Furukawa K. Practice guidelines for the management of pain. J Burn Care Res 2006; 27:659-668.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Faucher</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Furukawa</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Practice guidelines for the management of pain</article-title>
					<source>J Burn Care Res</source>
					<year>2006</year>
					<volume>27</volume>
					<fpage>659</fpage>
					<lpage>668</lpage>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. European Burns Association. Practice Guidelines for Burn Care, 2nd ed. Vienna; 2013.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<collab>European Burns Association</collab>
					</person-group>
					<source>Practice Guidelines for Burn Care</source>
					<edition>2</edition>
					<publisher-loc>Vienna</publisher-loc>
					<year>2013</year>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Larrea B, Avila M, Raddatz C. Manejo de dolor en pacientes quemados. Reu Chil Anest 2015; 44:78-95.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Larrea</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Avila</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Raddatz</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Manejo de dolor en pacientes quemados</article-title>
					<source>Reu Chil Anest</source>
					<year>2015</year>
					<volume>44</volume>
					<fpage>78</fpage>
					<lpage>95</lpage>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Midlands Burn Care Network, Guidelines For Pain and Itch Management For Patients Within The Midland Burn Care Network, Birmingham (England). 1 Ed. 2011.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<collab>Midlands Burn Care Network</collab>
					</person-group>
					 <source>Guidelines For Pain and Itch Management For Patients Within The Midland Burn Care Network</source>
					<publisher-loc>Birmingham (England)</publisher-loc>
					<edition>1</edition>
					<year>2011</year>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Alencar R, Cunha P, Kimiko R. Tratamiento del dolor en quemados. Reu Bras Anestesiol 2013; 63:149-158.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Alencar</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Cunha</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Kimiko</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Tratamiento del dolor en quemados</article-title>
					<source>Reu Bras Anestesiol</source>
					<year>2013</year>
					<volume>63</volume>
					<fpage>149</fpage>
					<lpage>158</lpage>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Aguilera F. Anestesia y manejo perioperatorio del paciente quemado. Reu Salud Bosque 2016; 6:65-78.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Aguilera</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Anestesia y manejo perioperatorio del paciente quemado</article-title>
					<source>Reu Salud Bosque</source>
					<year>2016</year>
					<volume>6</volume>
					<fpage>65</fpage>
					<lpage>78</lpage>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Macintyre P, Schug S, Scott D, et al; APM: SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence 3er ed. Melbourne: ANZCA &amp; FPM; 2010.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Macintyre</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Schug</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Scott</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>APM: SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine</collab>
					</person-group>
					<source>Acute Pain Management: Scientific Evidence 3er ed</source>
					<year>2010</year>
					<publisher-loc>Melbourne</publisher-loc>
					<publisher-name>ANZCA &amp; FPM</publisher-name>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Guidelines for Pain Management For patients within the Midland Burn Operational Delivery Network. Birmingham: Review date 2016.</mixed-citation>
				<element-citation publication-type="other">
					<source>Guidelines for Pain Management For patients within the Midland Burn Operational Delivery Network</source>
					<publisher-loc>Birmingham</publisher-loc>
					<date-in-citation content-type="access-date" iso-8601-date="2016-00-00">2016</date-in-citation>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Cordero I, Rodriguez R, Miquet L, et al. Conducta perioperatoria del paciente quemado. Reu Cub Anest Rean 2005; 4:75-92.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cordero</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Rodriguez</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Miquet</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Conducta perioperatoria del paciente quemado</article-title>
					<source>Reu Cub Anest Rean</source>
					<year>2005</year>
					<volume>4</volume>
					<fpage>75</fpage>
					<lpage>92</lpage>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Ministerio de Salud de Chile Guía Clínica gran Quemado. Santiago: Minsal. 2007.</mixed-citation>
				<element-citation publication-type="other">
					<source>Ministerio de Salud de Chile Guía Clínica gran Quemado</source>
					<publisher-name>Santiago</publisher-name>
					<publisher-loc>Minsal</publisher-loc>
					<year>2007</year>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal, anti-inflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized, controlled trials. Anesthesiology 2005; 102:1249-1260.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Marret</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Kurdi</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Zufferey</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Effects of nonsteroidal, anti-inflammatory drugs on patient-controlled analgesia morphine side effects meta-analysis of randomized, controlled trials</article-title>
					<source>Anesthesiology</source>
					<year>2005</year>
					<volume>102</volume>
					<fpage>1249</fpage>
					<lpage>1260</lpage>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Ramírez C, Ramírez C, Ramírez M, Ramírez N. Manejo del paciente quemado. Rev Univ Ind Santander Salud 2007:73-86.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ramírez</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Ramírez</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Ramírez</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Ramírez</surname>
							<given-names>N</given-names>
						</name>
					</person-group>
					<article-title>Manejo del paciente quemado</article-title>
					<source>Rev Univ Ind Santander Salud</source>
					<year>2007</year>
					<fpage>73</fpage>
					<lpage>86</lpage>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Richardson P, Mustard L. The management of pain in the burns unit. Burns 2009; 35:921-936.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Richardson</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Mustard</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>The management of pain in the burns unit</article-title>
					<source>Burns</source>
					<year>2009</year>
					<volume>35</volume>
					<fpage>921</fpage>
					<lpage>936</lpage>
				</element-citation>
			</ref>
			<ref id="B19">
				<mixed-citation>19. Ministerio de Salud de Chile Guías clínicas AUGE gran quemado. Santiago: Minsal 2016.</mixed-citation>
				<element-citation publication-type="book">
					<year>2016</year>
					<person-group person-group-type="author">
						<collab>Ministerio de Salud de Chile</collab>
					</person-group>
					<source>Guías clínicas AUGE gran quemado</source>
					<publisher-name>Santiago</publisher-name>
					<publisher-loc>Minsal</publisher-loc>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Zor F, Ozturk S, Bilgin F, et al. Pain relief during dressing changes of major adult burns: ideal analgesic combination with ketamine. Burns 2010; 36:501-505.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zor</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Ozturk</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Bilgin</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Pain relief during dressing changes of major adult burns ideal analgesic combination with ketamine</article-title>
					<source>Burns</source>
					<year>2010</year>
					<volume>36</volume>
					<fpage>501</fpage>
					<lpage>505</lpage>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21. Larrea B. Dolor en trauma térmico. Boletín el dolor 2006; 15:14-25.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Larrea</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Dolor en trauma térmico</article-title>
					<source>Boletín el dolor</source>
					<year>2006</year>
					<volume>15</volume>
					<fpage>14</fpage>
					<lpage>25</lpage>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>22. Morgan Ge. Morgan GE. Coadyuvantes de la Anestesia. Anestesiología Clínica 4 ed.2009; Mc Graw Hill, 277-279.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Ge</surname>
							<given-names>Morgan</given-names>
						</name>
						<name>
							<surname>Morgan</surname>
							<given-names>GE</given-names>
						</name>
					</person-group>
					<source>Coadyuvantes de la Anestesia. Anestesiología Clínica</source>
					<edition>4</edition>
					<year>2009</year>
					<publisher-name>Mc Graw Hill</publisher-name>
					<fpage>277</fpage>
					<lpage>279</lpage>
				</element-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation>23. Walker J, MacCallum M, Fischer C, et al. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006; 27:206-210.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Walker</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>MacCallum</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Fischer</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Sedation using dexmedetomidine in pediatric burn patients</article-title>
					<source>J Burn Care Res</source>
					<year>2006</year>
					<volume>27</volume>
					<fpage>206</fpage>
					<lpage>210</lpage>
				</element-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation>24. Kipping B, Rodger S, Miller K, et al. Virtual reality for acute pain reduction in adolescents undergoing burn wound care: a prospective randomized controlled trial. Burns 2012; 38:650657.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kipping</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Rodger</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Miller</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Virtual reality for acute pain reduction in adolescents undergoing burn wound care a prospective randomized controlled trial</article-title>
					<source>Burns</source>
					<year>2012</year>
					<volume>38</volume>
					<fpage>650657</fpage>
					<lpage>650657</lpage>
				</element-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation>25. Mott J, Bucolo S, Cuttle L, et al. The efficacy of an augmented virual reality system to alleviate pain in children undergoing burns dressing changes: a randomised controlled trial. Burns 2008; 34:803-808.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mott</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Bucolo</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Cuttle</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>The efficacy of an augmented virual reality system to alleviate pain in children undergoing burns dressing changes a randomised controlled trial</article-title>
					<source>Burns</source>
					<year>2008</year>
					<volume>34</volume>
					<fpage>803</fpage>
					<lpage>808</lpage>
				</element-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation>26. Hoffman H, Chambers G, Meyer W, et al. Virtual reality as an adjunctive non-pharmacologic analgesic for acute burn pain during medical procedures. Ann Behau Med 2011; 41:183-191.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hoffman</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Chambers</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Meyer</surname>
							<given-names>W</given-names>
						</name>
					</person-group>
					<article-title>Virtual reality as an adjunctive non-pharmacologic analgesic for acute burn pain during medical procedures</article-title>
					<source>Ann Behau Med</source>
					<year>2011</year>
					<volume>41</volume>
					<fpage>183</fpage>
					<lpage>191</lpage>
				</element-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation>27. Jonhson S, Coxon M. Sound can enhance the analgesic effect of virtual reality. R Soc Open Sci 2016; 3:150567.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jonhson</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Coxon</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Sound can enhance the analgesic effect of virtual reality</article-title>
					<source>R Soc Open Sci</source>
					<year>2016</year>
					<volume>3</volume>
					<fpage>150567</fpage>
					<lpage>150567</lpage>
				</element-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation>28. Hoffman H, Sharar S, Coda B, et al. Manipulating presence influences the magnitude of virtual reality analgesia. Pain 2004; 111:162-168.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hoffman</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Sharar</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Coda</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Manipulating presence influences the magnitude of virtual reality analgesia</article-title>
					<source>Pain</source>
					<year>2004</year>
					<volume>111</volume>
					<fpage>162</fpage>
					<lpage>168</lpage>
				</element-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation>29. Morris L, Louw Q Grimmer-Somers K. The effectiveness of virtual reality on reducing pain and anxiety in burn injury patients: a systematic review. Clin J Pain 2009; 25:815-826.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Morris</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<collab>Louw Q Grimmer-Somers K</collab>
					</person-group>
					<article-title>The effectiveness of virtual reality on reducing pain and anxiety in burn injury patients a systematic review</article-title>
					<source>Clin J Pain</source>
					<year>2009</year>
					<volume>25</volume>
					<fpage>815</fpage>
					<lpage>826</lpage>
				</element-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation>30. Vásquez K, García R, Cruz M, et al. Electroterapia como manejo alternativo del dolor en quemaduras. Reu San Milit Mex 2008; 62:141-144.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Vásquez</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>García</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Cruz</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Electroterapia como manejo alternativo del dolor en quemaduras</article-title>
					<source>Reu San Milit Mex</source>
					<year>2008</year>
					<volume>62</volume>
					<fpage>141</fpage>
					<lpage>144</lpage>
				</element-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation>31. Gandhi M, Thomson C, Lord D, et al. Management of pain in children with burns. Int J Pediatr 2010; 2010:1-9.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gandhi</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Thomson</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Lord</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<article-title>Management of pain in children with burns</article-title>
					<source>Int J Pediatr</source>
					<year>2010</year>
					<volume>2010</volume>
					<fpage>1</fpage>
					<lpage>9</lpage>
				</element-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation>32. Grey P, Kirby J, Smith M, et al. Pregabalin in severe burn injury pain: a double-blind, randomized placebo-controlled trial. Pain 2011; 52:1279-1288.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Grey</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Kirby</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Smith</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Pregabalin in severe burn injury pain a double-blind, randomized placebo-controlled trial</article-title>
					<source>Pain</source>
					<year>2011</year>
					<volume>52</volume>
					<fpage>1279</fpage>
					<lpage>1288</lpage>
				</element-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation>33. Grey P. Acute neuropathic pain, diagnosis and treatment. Curr Opin Anaesthesiol 2008; 21:590-595.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Grey</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Acute neuropathic pain, diagnosis and treatment</article-title>
					<source>Curr Opin Anaesthesiol</source>
					<year>2008</year>
					<volume>21</volume>
					<fpage>590</fpage>
					<lpage>595</lpage>
				</element-citation>
			</ref>
			<ref id="B34">
				<label>34</label>
				<mixed-citation>34. Wong L, Turner L. Treatment of postburn neuropathic pain: evaluation of pregrabalin. Burns 2010; 36:769-772.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wong</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Turner</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Treatment of postburn neuropathic pain evaluation of pregrabalin</article-title>
					<source>Burns</source>
					<year>2010</year>
					<volume>36</volume>
					<fpage>769</fpage>
					<lpage>772</lpage>
				</element-citation>
			</ref>
			<ref id="B35">
				<label>35</label>
				<mixed-citation>35. Cuignet O, Pirson J, Soudon O, et al. Effects of gabapentin on morphine consumption and pain in severely burned patients. Burns 2007; 33:81-86.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cuignet</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Pirson</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Soudon</surname>
							<given-names>O</given-names>
						</name>
					</person-group>
					<article-title>Effects of gabapentin on morphine consumption and pain in severely burned patients</article-title>
					<source>Burns</source>
					<year>2007</year>
					<volume>33</volume>
					<fpage>81</fpage>
					<lpage>86</lpage>
				</element-citation>
			</ref>
			<ref id="B36">
				<label>36</label>
				<mixed-citation>36. Grey P, Williams B, Cramond T. Successful use of gabapentin in acute pain management following burn injury: a case series. Pain Med 2008; 9:371-376.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Grey</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Williams</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Cramond</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<article-title>Successful use of gabapentin in acute pain management following burn injury a case series</article-title>
					<source>Pain Med</source>
					<year>2008</year>
					<volume>9</volume>
					<fpage>371</fpage>
					<lpage>376</lpage>
				</element-citation>
			</ref>
			<ref id="B37">
				<label>37</label>
				<mixed-citation>37. Ahuja R, Chatterjee P. Postburn pruritus: a practical review. Indian J Burns 2014; 22:13-22.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ahuja</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Chatterjee</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Postburn pruritus a practical review</article-title>
					<source>Indian J Burns</source>
					<year>2014</year>
					<volume>22</volume>
					<fpage>13</fpage>
					<lpage>22</lpage>
				</element-citation>
			</ref>
			<ref id="B38">
				<label>38</label>
				<mixed-citation>38. Ahuja R, Gupta G. A four arm, double blind, randomized and placebo controlled study of pregabalin in the management of postburn pruritus. Burns 2013; 39:24-29.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ahuja</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Gupta</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<article-title>A four arm, double blind, randomized and placebo controlled study of pregabalin in the management of postburn pruritus</article-title>
					<source>Burns</source>
					<year>2013</year>
					<volume>39</volume>
					<fpage>24</fpage>
					<lpage>29</lpage>
				</element-citation>
			</ref>
			<ref id="B39">
				<label>39</label>
				<mixed-citation>39. Goutos I, Eldardiri M, Khan A, et al. Comparative evaluation of antipruritic protocols in acute burns. The emerging value of gabapentin in the treatment of burn pruritus. J Burn Care Res 2010; 31:57-63.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Goutos</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Eldardiri</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Khan</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Comparative evaluation of antipruritic protocols in acute burns The emerging value of gabapentin in the treatment of burn pruritus</article-title>
					<source>J Burn Care Res</source>
					<year>2010</year>
					<volume>31</volume>
					<fpage>57</fpage>
					<lpage>63</lpage>
				</element-citation>
			</ref>
			<ref id="B40">
				<label>40</label>
				<mixed-citation>40. Goutos I. Review of therapeutic agents for burns pruritus and protocols for management in adult and pediatric patients using the grade classification. Indian J Plast Surg 2010; 43:51-62.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Goutos</surname>
							<given-names>I</given-names>
						</name>
					</person-group>
					<article-title>Review of therapeutic agents for burns pruritus and protocols for management in adult and pediatric patients using the grade classification</article-title>
					<source>Indian J Plast Surg</source>
					<year>2010</year>
					<volume>43</volume>
					<fpage>51</fpage>
					<lpage>62</lpage>
				</element-citation>
			</ref>
			<ref id="B41">
				<label>41</label>
				<mixed-citation>41. Orellana M, Yañez , Gutiérrez J, et al. Prurito neuropático. Reuista el dolor 2012; 57:28-32.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Orellana</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Yañez</surname>
							<given-names/>
						</name>
						<name>
							<surname>Gutiérrez</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Prurito neuropático</article-title>
					<source>Reuista el dolor</source>
					<year>2012</year>
					<volume>57</volume>
					<fpage>28</fpage>
					<lpage>32</lpage>
				</element-citation>
			</ref>
			<ref id="B42">
				<label>42</label>
				<mixed-citation>42. Goutos I. Neuropathic mechanisms in the pathophysiology of burns pruritus: redefining directions for therapy and research. J Burn Care Res 2013; 34:82-93.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Goutos</surname>
							<given-names>I</given-names>
						</name>
					</person-group>
					<article-title>Neuropathic mechanisms in the pathophysiology of burns pruritus redefining directions for therapy and research</article-title>
					<source>J Burn Care Res</source>
					<year>2013</year>
					<volume>34</volume>
					<fpage>82</fpage>
					<lpage>93</lpage>
				</element-citation>
			</ref>
			<ref id="B43">
				<label>43</label>
				<mixed-citation>43. Connolly S. Clinical Practice Guidelines: Burn Patient Management. Sydney: Agency for Clinical Innovation, 2011.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Connolly</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<source>Clinical Practice Guidelines: Burn Patient Management</source>
					<year>2011</year>
					<publisher-loc>Sydney</publisher-loc>
					<publisher-name>Agency for Clinical Innovation</publisher-name>
				</element-citation>
			</ref>
			<ref id="B44">
				<label>44</label>
				<mixed-citation>44. Moix J. La hipnosis en el tratamiento del dolor. Reu Soc Esp Dolor 2002; 9:525-532.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Moix</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>La hipnosis en el tratamiento del dolor</article-title>
					<source>Reu Soc Esp Dolor</source>
					<year>2002</year>
					<volume>9</volume>
					<fpage>525</fpage>
					<lpage>532</lpage>
				</element-citation>
			</ref>
			<ref id="B45">
				<label>45</label>
				<mixed-citation>45. Boyer E. Management of opiod analgesic overdose. N Engl J Med 2012; 367:146-155.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Boyer</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title>Management of opiod analgesic overdose</article-title>
					<source>N Engl J Med</source>
					<year>2012</year>
					<volume>367</volume>
					<fpage>146</fpage>
					<lpage>155</lpage>
				</element-citation>
			</ref>
			<ref id="B46">
				<label>46</label>
				<mixed-citation>46. Mugabure B, González S, Uría A, et al. Actualizaciones en el manejo clínico de los opioides espinales en el dolor agudo postoperatorio. Reu Soc Esp Dolor 2012; 19:72-94.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mugabure</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>González</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Uría</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Actualizaciones en el manejo clínico de los opioides espinales en el dolor agudo postoperatorio</article-title>
					<source>Reu Soc Esp Dolor</source>
					<year>2012</year>
					<volume>19</volume>
					<fpage>72</fpage>
					<lpage>94</lpage>
				</element-citation>
			</ref>
			<ref id="B47">
				<label>47</label>
				<mixed-citation>47. Cadavid A. Analgesia opioide en el postoperatorio, en: Opiodes en la práctica médica. 2009; Asociación colombiana para el estudio del dolor, Bogotá (Colombia):45-66.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Cadavid</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<chapter-title>Analgesia opioide en el postoperatorio</chapter-title>
					<source>Opiodes en la práctica médica</source>
					<year>2009</year>
					<publisher-name>Asociación colombiana para el estudio del dolor</publisher-name>
					<publisher-loc>Bogotá (Colombia)</publisher-loc>
					<fpage>45</fpage>
					<lpage>66</lpage>
				</element-citation>
			</ref>
			<ref id="B48">
				<label>48</label>
				<mixed-citation>48. Acuña J. Intoxicación grave por psicofármacos. Reu Med Clin Condes 2011; 22:332-339.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Acuña</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Intoxicación grave por psicofármacos</article-title>
					<source>Reu Med Clin Condes</source>
					<year>2011</year>
					<volume>22</volume>
					<fpage>332</fpage>
					<lpage>339</lpage>
				</element-citation>
			</ref>
			<ref id="B49">
				<label>49</label>
				<mixed-citation>49. Oses I, Burillo-Putze G, Munne P, et al. Intoxcaciones medicamentosas, psicofármacos y antiarrítmicos. ANALES Sis San Nauarra 2003; 26:49-63.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Oses</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Burillo-Putze</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Munne</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Intoxcaciones medicamentosas, psicofármacos y antiarrítmicos</article-title>
					<source>ANALES Sis San Nauarra</source>
					<year>2003</year>
					<volume>26</volume>
					<fpage>49</fpage>
					<lpage>63</lpage>
				</element-citation>
			</ref>
			<ref id="B50">
				<label>50</label>
				<mixed-citation>50. Eslava S. Aguilera F. Anestésicos endovenosos. Anestesiología y Medicina Perioperatoria 4th ed. Celsus: Bogotá; 2010; 158-164.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Eslava</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Aguilera</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<source>Anestésicos endovenosos. Anestesiología y Medicina Perioperatoria</source>
					<year>2010</year>
					<edition>4</edition>
					<publisher-loc>Celsus</publisher-loc>
					<publisher-name>Bogotá</publisher-name>
				</element-citation>
			</ref>
			<ref id="B51">
				<label>51</label>
				<mixed-citation>51. Zapantis A, Leung S. Tolerance and withdrawal issues with sedation. Crit Care Nurs Clin North Am 2005; 17:211-223.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zapantis</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Leung</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Tolerance and withdrawal issues with sedation</article-title>
					<source>Crit Care Nurs Clin North Am</source>
					<year>2005</year>
					<volume>17</volume>
					<fpage>211</fpage>
					<lpage>223</lpage>
				</element-citation>
			</ref>
			<ref id="B52">
				<label>52</label>
				<mixed-citation>52. Rivera R. Sedación y analgesia: una revisión. Acta Pediátr Costarricense 2002; 16:6-21.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rivera</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Sedación y analgesia una revisión</article-title>
					<source>Acta Pediátr Costarricense</source>
					<year>2002</year>
					<volume>16</volume>
					<fpage>6</fpage>
					<lpage>21</lpage>
				</element-citation>
			</ref>
			<ref id="B53">
				<label>53</label>
				<mixed-citation>53. Galinkin J, Lee J. Recognition and management of iatrogenically-induced opioid dependence and withdrawal in children. Pediatrics 2014; 133:152-155.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Galinkin</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Lee</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Recognition and management of iatrogenically-induced opioid dependence and withdrawal in children</article-title>
					<source>Pediatrics</source>
					<year>2014</year>
					<volume>133</volume>
					<fpage>152</fpage>
					<lpage>155</lpage>
				</element-citation>
			</ref>
			<ref id="B54">
				<label>54</label>
				<mixed-citation>54. Suttner J, White A, Vernachio K. Best practices in tapering methods in patients undergoing opioid therapy. Adu Pharmacol Pharm 2013; 1:42-57.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Suttner</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>White</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Vernachio</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Best practices in tapering methods in patients undergoing opioid therapy</article-title>
					<source>Adu Pharmacol Pharm</source>
					<year>2013</year>
					<volume>1</volume>
					<fpage>42</fpage>
					<lpage>57</lpage>
				</element-citation>
			</ref>
			<ref id="B55">
				<label>55</label>
				<mixed-citation>55. Celis E, Besso J, Birchenall C, et al. Guía de práctica clínica basada en la evidencia para el manejo de la sedoanalgesia en el paciente adulto críticamente enfermo. Med Intensiva 2007; 31:428-471.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Celis</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Besso</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Birchenall</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Guía de práctica clínica basada en la evidencia para el manejo de la sedoanalgesia en el paciente adulto críticamente enfermo</article-title>
					<source>Med Intensiva</source>
					<year>2007</year>
					<volume>31</volume>
					<fpage>428</fpage>
					<lpage>471</lpage>
				</element-citation>
			</ref>
			<ref id="B56">
				<label>56</label>
				<mixed-citation>56. Baltieri D, Strain E, Dias J, et al. Brazilian guideline for the treatment of patients with opioids dependence syndrome. Reu Bras Psiquiatr 2004; 26:259-268.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Baltieri</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Strain</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Dias</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Brazilian guideline for the treatment of patients with opioids dependence syndrome</article-title>
					<source>Reu Bras Psiquiatr</source>
					<year>2004</year>
					<volume>26</volume>
					<fpage>259</fpage>
					<lpage>268</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other" id="fn1">
				<label>How to cite this article:</label>
				<p> Cáceres-Jerez LE, Gomezese-Ribero OF, Reyes-Cárdenas LI, Vera-Campos JA, Guzmán-Rueda VA, Azar-Villalobos JP, Meléndez-Flórez HJ. Management of acute pain in extensive burn injury: Nonsystematic review of the literature. Rev Colomb Anestesiol. 2018;46:49-54.</p>
			</fn>
			<fn fn-type="other" id="fn2">
				<label>Funding</label>
				<p> The authors declare not having received external funding.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="other" id="fn3">
				<label>Conflicts of interest</label>
				<p> The authors declare having no conflict of interest to disclose.</p>
			</fn>
		</fn-group>
	</back>
	<!--sub-article article-type="translation" id="s1" xml:lang="es">
		<front-stub>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>REVISIÓN</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Manejo del dolor agudo en el paciente gran quemado: Revisión no sistemática de la literatura</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Cáceres-Jerez</surname>
						<given-names>Luz Elena</given-names>
					</name>
					<xref ref-type="aff" rid="aff7"><sup>a</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Gomezese-Ribero</surname>
						<given-names>Omar Fernando</given-names>
					</name>
					<xref ref-type="aff" rid="aff8"><sup>b</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Reyes-Cárdenas</surname>
						<given-names>Laura Isabel</given-names>
					</name>
					<xref ref-type="aff" rid="aff9"><sup>c</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Vera-Campos</surname>
						<given-names>Julián Andrés</given-names>
					</name>
					<xref ref-type="aff" rid="aff10"><sup>d</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Guzmán-Rueda</surname>
						<given-names>Valentina Alejandra</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>e</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Azar-Villalobos</surname>
						<given-names>Juan Pablo</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>e</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Meléndez-Flórez</surname>
						<given-names>Héctor Julio</given-names>
					</name>
					<xref ref-type="aff" rid="aff12"><sup>f</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff7">
				<label>a</label>
				<institution content-type="original"> Coordinadora académica, Clínica del Dolor y Cuidado Paliativo, Fundación Cardiovascular de Colombia, Floridablanca, Colombia</institution>
				<institution content-type="orgname">Fundación Cardiovascular de Colombia</institution>
				<addr-line>
					<named-content content-type="state">Floridablanca</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff8">
				<label>b</label>
				<institution content-type="original"> Director Clínica del Dolor y Cuidado Paliativo, Fundación Cardiovascular de Colombia, Docente del posgrado de Anestesiología y Reanimación de la Universidad Industrial de Santander, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<addr-line>
					<named-content content-type="city">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff9">
				<label>c</label>
				<institution content-type="original"> Médica asistencial, Fundación Cardiovascular de Colombia, Floridablanca, Colombia</institution>
				<institution content-type="orgname">Fundación Cardiovascular de Colombia</institution>
				<addr-line>
					<named-content content-type="city">Floridablanca</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff10">
				<label>d</label>
				<institution content-type="original"> Residente de Anestesiología y Reanimación, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Autónoma de Bucaramanga</institution>
				<institution content-type="orgname">Universidad Autónoma de Bucaramanga</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff11">
				<label>e</label>
				<institution content-type="original"> Residente de Anestesiología y Reanimación, Universidad Industrial de Santander, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff12">
				<label>f</label>
				<institution content-type="original"> Coordinador académico de la Unidad de Cuidados Intensivos del Hospital Universitario de Santander, Docente del posgrado de Anestesiología y Reanimación de la Universidad Industrial de Santander, Bucaramanga, Colombia</institution>
				<institution content-type="normalized">Universidad Industrial de Santander</institution>
				<institution content-type="orgname">Universidad Industrial de Santander</institution>
				<addr-line>
					<named-content content-type="state">Bucaramanga</named-content>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<author-notes>
				<corresp id="c2">
					<label> </label><bold>Correspondencia:</bold> Fundación Cardiovascular de Colombia. Calle 155 A No. 23-58. Urbanización El Bosque. Departamento de Neurociencias. Floridablanca, Colombia. Correo electrónico: investigaciondolorfcv@hotmail.com</corresp>
			</author-notes>
			<abstract>
				<title>Resumen</title>
				<sec>
					<title>Introducción: </title>
					<p>El manejo del dolor agudo es fundamental en el tratamiento de los pacientes quemados. Los esquemas actuales de manejo de dolor se enfocan en el control del componente somático que refleja la noxa, sin embargo es un evento con componentes emocionales, físico y psíquicos, que requiere manejo multidisciplinario incluyendo intervenciones farmacológicas y no farmacológicas, para romper el círculo vicioso del dolor y sus complicaciones.</p>
				</sec>
				<sec>
					<title>Objetivo: </title>
					<p>Realizar una revisión no sistemática de la literatura sobre el manejo farmacológico y no farmacológico del dolor agudo en el paciente gran quemado.</p>
				</sec>
				<sec>
					<title>Metodología: </title>
					<p>Se realizó una revisión no sistemática en MEDLINE/PubMed, Embase, Science Direct, SciELO, LILACS, Google Scholar, libros académicos, guías de manejo institucionales, desde el año 2000 hasta el 2016.</p>
				</sec>
				<sec>
					<title>Resultados: </title>
					<p>Luego de analizar la literatura se encuentra que el manejo del dolor agudo en el paciente gran quemado debe recibir un enfoque multidisciplinario.</p>
				</sec>
				<sec>
					<title>Conclusiones: </title>
					<p>El manejo agudo del dolor en el paciente gran quemado no se debe centrar solamente en los componentes somáticos del mismo, sino que debe extenderse a los componentes emocionales físicos y psicosociales, para brindar un manejo integral, tanto farmacológico como no farmacológico.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Dolor</kwd>
				<kwd>Dolor Agudo</kwd>
				<kwd>Analgésico</kwd>
				<kwd>Quemaduras</kwd>
				<kwd>Manejo del Dolor</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<sec sec-type="intro">
				<title>Introducción y objetivos</title>
				<p>Uno de los pilares fundamentales del tratamiento de pacientes con quemaduras en fase aguda es el manejo efectivo del dolor, lo que significa además, el manejo indirecto y precoz de las complicaciones que pueden surgir de la atención inefectiva del mismo, tanto a corto plazo (trombosis venosa, hipertensión con órgano blanco, taquicardia, evento coronario, hiperglicemia, inmunosupresión, entre otras) como a largo plazo (dolor neuropático, depresión, ansiedad, contracturas articulares).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>
				</p> <p>En la literatura actual, los esquemas de manejo de dolor en pacientes que sufren quemaduras se enfocan en el control del componente somático que refleja la noxa traumática; sin embargo, el dolor en quemaduras es un suceso mucho más complejo, que implica compromiso en múltiples niveles (físico, emocional y psíquico), e involucra mecanismos fisiopatológicos que significan mucho más que un fenómeno controlable con la administración de opioides, debiéndose involucrar, por tanto, un manejo basado en la mejor evidencia disponible, realizado por un grupo multidisciplinario, y que incluya intervenciones tanto farmacológicas como no farmacológicas,<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> con el fin de romper el círculo vicioso del dolor y las complicaciones enunciadas anteriormente, que podrían desencadenarse tras la lesión por quemadura.</p>
				<p>Por todo lo anterior surgió la necesidad de realizar una revisión no sistemática de literatura sobre el manejo integral del dolor agudo en el paciente gran quemado, sintetizando los hallazgos más relevantes, para ser aplicado en el Hospital Universitario de Santander uno de los pocos centros médicos del país que cuenta con unidad de atención de pacientes quemados, este documento fue desarrollado por la Universidad Industrial de Santander, y tiene como fin brindar pautas en el manejo agudo del dolor en esta población de pacientes, para ser aplicadas en cualquier punto de la atención aguda, no solo limitándose al manejo en un tercer o cuarto nivel de atención en salud en nuestro país.</p>
			</sec>
			<sec sec-type="methods">
				<title>Metodología</title>
				<p>Se realizó una revisión no sistemática de literatura desde el año 2000 hasta el año 2016, provenientes de bases de datos como: MEDLINE/PUBMED, Embase, Science Direct, SciELO, LILACS, Google scholar, libros académicos, guías de manejo institucionales o documentos regulatorios, con lossiguientestérminosde busqueda en inglés y español como: Acute pain, Burns, Analgesics, therapy, pathophysiology of burns, non-pharmacologic analgesic for acute burn pain, management of pain in children burns, virutal reality in burn pain, opioid withdrawal, opioid overdose, management of pruritus in burns, Dolor agudo en quemados, quemadura, analgesia, manejo perioperatorio en quemados, manejo de dolor en el paciente pediátrico quemado, sobre-dosis con opioides, destete de opioides, manejo del prurito en quemados. Se consideraron meta-análisis, ensayos clínicos, estudios observacionales, artículos de revisión, series de casos, guías de manejo y libros, excluyendo aquellos que no aportaban información relevante sobre manejo agudo y los que no cumplían con la fecha de bu squeda (<xref ref-type="fig" rid="f2">Figura 1</xref>). Se realiza lectura de los artículos encontrados por parte de los autores, seleccionando los referenciados en la bibliografía, los resultados de esta revisión se presentan a continuación, bajo el punto de vista de los autores.</p>
				<p>
					<fig id="f2">
						<label>Figura 1</label>
						<caption>
							<title>Flujograma de búsqueda y selección.</title>
						</caption>
						<graphic xlink:href="0120-3347-rca-46-01-00049-gf2.png"/>
						<attrib>Fuente: Autores.</attrib>
					</fig>
				</p>
			</sec>
			<sec>
				<title>Desarrollo del tema</title>
				<sec>
					<title><italic>Evaluación del dolor</italic></title>
					<p>La evaluación del dolor se debe realizar antes, durante y después de un procedimiento álgico, también a los 30 minutos de una intervención analgésica, ésta debe ser objetiva con base en un horario regular con un instrumento validado como por ejemplo:<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref>
					</p> <p>Visual Analogue Scale (VAS, sigla en inglés), o Escala Visual Análoga, en mayores de 12 años.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
					</p> <p>Verbal Numeric Scale (VNS, sigla en inglés) o Escala Verbal Numérica, en mayores de 12 años, y en escenarios donde hayan limitaciones en comprensión de VAS.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
					</p> <p>Verbal Global Scale (VGS, sigla en inglés), o Escala Verbal global, en mayores de 12 años, y en escenarios donde hayan limitaciones en comprensión de VAS y VNS.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
					</p> <p>Smiles Pain Rating Scale (SRPS, sigla en inglés), o Escala de Evaluación de dolor con Caras Sonrientes, en pacientes de 5 - 12 años.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
					</p> <p>FLACC (sigla en inglés): Facies de dolor, movimientos de miembros inferiores, agitación, consolabilidad y llanto, en menores de 5 años.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo farmacológico: generalidades</italic></title>
					<p>Los fármacos opioides potentes son la piedra angular del manejo de dolor agudo causado por quemaduras.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Se sugiere iniciar manejo con fármacos opioides potentes y luego desescalar, en lugar de ir escalando en potencia.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref> En todo servicio donde dichos fármacos se utilicen rutinariamente, se deberá contar con acceso a fuentes de oxígeno, equipos para reanimación cardio cerebro pulmonar (RCCP), personal entrenado en la misma y naloxona.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref> Adicionalmente se deben prever y tratar agresivamente los efectos secundarios a la administración de opioides.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref>
					</p> <p>Los procedimientos intensamente dolorosos, o no tolerados por el paciente, se deben realizar bajo anestesia general.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo de dolor de base: paracetamol y antiinflaamatorios no esteroideos (AINEs)</italic></title>
					<p>Se sugiere indicar a todos los pacientes acetaminofén<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref> por horario (500 mg cada 6 horas en adultos, 10 - 15mg/kg dosis cada 6 horas en niños vía oral (v.o), como parte del manejo de dolor de base, a menos que esté contraindicado.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Se puede considerar la adición de (AINEs) por horario<xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref> (ibuprofeno 400 mg vía oral cada 8 horas, 10mg/kg dosis cada 8 horas en niños mayores de 6 meses, o diclofenaco 50 mg v.o cada 12 horas, 75 mg intravenoso (i.v) cada 12 horas en adultos, 1-2mg/kg cada 12 horas en niños mayores de 5 años) en ciclo corto (máximo 3 días), el acetaminofén por horario en pacientes no críticos, con v.o preservada en fase aguda de quemadura.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo de dolor de base: opioides</italic></title>
					<p>En caso de no lograrse el control del dolor con la administración de acetaminofén o el ciclo corto de AINEs, se debe adicionar al manejo farmacológico un agonista opioide débil por horario, como el tramadol a 1mg/kg/ dosis cada 6-8 horas en niños o 50 - 100 mg i.v cada 6 - 8 horas, máximo 400 mg día en adultos, o codeína 1mg/kg/ dosis cada 6 - 8 horas en niños, o 30 - 60 mg vía oral cada 6 horas en adultos, máximo 240 mg al día.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref>
					</p> <p>Si las medidas anteriores no son suficientes para controlar adecuadamente el dolor, se deberá iniciar el manejo farmacológico con un agonista opioide fuerte por horario, teniendo la precaución de suspender primero la administración de opioide débil, así: titulación de morfina con dosis bajas (1 - 2mg en adultos, 0,01mg/ kg en niños) i.v cada 5 - 10 minutos hasta control del dolor, o presencia de somnolencia, dejando la dosis total titulada cada 4-6 horas si se prevé que la causa del dolor continuará.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
					</p> <p>Si no se dispone de opioide fuerte, en lugar del opioide débil, se puede administrar un opioide agonista -antagonista por horario tipo nalbufina a 0,4mg/kg/dosis cada 4-6 horas.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo de dolor incidental</italic></title>
					<p>Otra opción del manejo agudo es la analgesia controlada por el paciente, (PCA por sus siglas en inglés), cuya utilidad principal se encuentra en el manejo del dolor incidental. Se recomienda el uso de PCA de fentanilo con bolo inicial 1 mcg/kg, demandas de 30 mcg, con intervalo de cierre 5 minutos, o morfina intravenosa 0,05 - 0,2 mg/kg/dosis cada 4 - 6 horas.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref> También es util en el manejo de dolor incidental el uso de meperidina 1 mg/kg/dosis (máximo 4 dosis en total).<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo de dolor procedimental</italic></title>
					<p>Para el manejo de dolor causado por la realización de procedimientos en esta población de pacientes, tenemos varias opciones con alta calidad de evidencia. La primera de ellas es la aplicación de opioide fuerte previo al procedimiento (morfina 0,05 - 0,2mg/kg 10 minutos antes, o fentanilo 1mcg/kg 5 minutos antes) o el uso de PCA asociado a una benzodiacepina previa al procedimiento (midazolam 0,05 mg/kg 30 minutos - 1 hora antes)<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref> La asociación de Ketamina se ha utilizado ampliamente por más de 40 años en pacientes quemados, pero su uso se había reducido por sus efectos secundarios, los cuales se pueden evitar con la asocia-ción de una benzodiacepina. Laketaminaadosis de 1mg/kg con una benzodiacepina (midazolam 0,05 mg/ kg) y un antisialagogo (atropina 0,01mg/kg) es una excelente opción analgésica, siempre y cuándo se administre en instalaciones dónde se cuente con anestesiólogo.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>
					</p> <p>Otra asociación de fármacos con excelente efecto analgésico en dolor procedimental es el uso de dexme-detomidina bolo 1mcg/kg, asociado a Ketamina bolo 2 mg/kg y Tramadol 1 mg/kg, en instalaciones equivalentes a cuidado intermedio, con presencia de personal entrenado en RCCP o anestesiólogo.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref>
					</p> <p>Por otra parte dentro de las intervenciones no farmacológicas, en adolescentes se encuentra la asociación de realidad virtual, realizada en instalaciones con la infraestructura adecuada y personal debidamente entrenado,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref> así como el uso de estimulación eléctricatranscutánea(TENS), antes, durante y después del procedimiento, previa explicación al paciente, y en asociación con esquemas farmacológicos.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo de dolor postoperatorio</italic></title>
					<p>Considerar desde el servicio de Anestesiología de Cirugía Plástica, involucrar esquemas de analgesia sistémica preventiva con AINEs o acetaminofén sistémico antes del procedimiento,<xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref> anestesia tumescente,<sup>(6</sup> bloqueos regionales<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref> o lidocaína tópica en curaciones<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref> buscando brindar efecto analgésico residual posterior al procedimiento quirúrgico - anestésico. En Pacientes estables, que toleren la vía oral, se puede considerar el uso de opioides débiles como codeína a dosis entre 30 - 60 mg cada 6 horas, con dosis máxima 240 mg día, buscando activamente, y tratando oportunamente efectos secundarios. Asimismo, se puede considerar el uso de oxicodona convencional, a dosis de 5 -10 mg cada 8 horas, o fórmula de liberación prolongada cada 12 - 24 horas, Metadona 2,5 - 5mg cada 6 horas, o Hidrocodona 5 - 10 mg cada 4 - 6 horas. Se debe procurar no usar opioides orales por más de 10 días, con el fin de evitar dependencia física.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo de dolor neuropático</italic></title>
					<p>Dadas las características de las lesiones en los pacientes que sufren quemaduras, es coimin que se presente dolor neuropático en esta población, por lo que se recomienda la asociación precoz de pregabalina que ha demostrado eficacia clínica en la reducción del dolor neuropatico a nivel periférico y central, a dosis tituladas desde 37,5 mg con opioide por v.o ante dolor de dichas características.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B34"><sup>34</sup></xref> En situaciones donde no se cuente con acceso a pregabalina, se debe considerar el uso de gabapentina titulada desde 300 mg v.o al día.<xref ref-type="bibr" rid="B33"><sup>33</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B36"><sup>36</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Prurito</italic></title>
					<p>El prurito debe ser tratado con medidas farmacológicas como gabapentina en dosis incrementales desde 300mg hasta 1500mg/día v.o<xref ref-type="bibr" rid="B37"><sup>37</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B42"><sup>42</sup></xref> y no farmacológicas efectivas,<xref ref-type="bibr" rid="B37"><sup>37</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref> recordando que la v.o puede ser una vía de administración de medicamentos en quemaduras leves,<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref> y que no deben usarse las vías intramuscular ni subcutánea en fases agudas de quemadura.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Manejo no farmacológico</italic></title>
					<p>Se deben ofrecer opciones no farmacológicas junto con las opciones farmacológicas.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref> En servicios con instalaciones adecuadas y personal entrenado, se podrían ofrecer como estrategias de manejo no farmacológico musicoterapia, hipnosis, esquemas de realidad virtual no inmersiva (imágenes, videos, videojuegos) o inmersiva, y psicoterapia pre, postprocedimiento y transterapéutico.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B44"><sup>44</sup></xref>
					</p> </sec>
			</sec>
			<sec>
				<title>Manejo de complicaciones secundarias al uso de medicamentos para el manejo analgésico en pacientes quemados</title>
				<sec>
					<title><italic>Depresión respiratoria por opioides</italic></title>
					<p>El uso de opioides a dosis elevadas en los pacientes con quemaduras conlleva el riesgo de que se presenten eventos adversos secundarios al uso de los mismos. De ellos, el efecto adverso más grave es la depresión respiratoria. Es necesario reconocerla o sospecharla rápidamente si nos enfrentamos a un paciente con antecedente confirmado de administración de dosis elevadas de opioides, que presente una frecuencia respiratoria inferior a 8 por minuto, miosis, oximetría de pulso inferior a 90% y somnolencia o estupor. La respuesta debe ser inmediata, avisando prioritariamente al servicio de anestesiología de urgencias e iniciando estimulación táctil y auditiva al paciente, sumado a la titulación de naloxona, con dosis de lmcg/kg intravenoso cada 3 a 5 minutos hasta que se resuelva la bradipnea o el paciente presente recuperación de estado de conciencia y saturación arterial de oxígeno de 91% o superior. El médico que brinda la atención debe evaluar si el paciente requiere manejo básico y/o avanzado de la vía aérea y ventilación, de acuerdo a lineamientos sobre RCCP, sobre los cuales debe estar capacitado. Se debe vigilar la eventualidad de renarcotización, dependiendo del opioide causante de depresión, y de la forma de uso.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B45"><sup>45</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B47"><sup>47</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Depresión respiratoria por benzodiazepinas</italic></title>
					<p>Ante sospecha de depresión respiratoria secundaria al uso de benzodiacepinas, se recomienda administrar flumaze-nil 0,2 mg IV cada minuto hasta recuperación de estado de conciencia, seguir los demás lineamentos descritos anteriormente en el apartado de manejo de depresión respiratoria por opioides.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B48"><sup>48</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B49"><sup>49</sup></xref>
					</p> </sec>
				<sec>
					<title><italic>Crisis psicomimética por ketamina</italic></title>
					<p>Ante alteración sensoperceptiva (alucinaciones, ilusiones) o conductual (agitación, inatención) del paciente, sospechada por la administración de ketamina, se recomienda avisar al servicio de anestesiología de urgencias prioritariamente y simultáneamente administrar midazolam dosis de 0,05mg/kg.<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B49"><sup>49</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B50"><sup>50</sup></xref>
					</p> <p>Destete de opioides fuertes parenterales en unidad de cuidados intermedios - cuidados intensivos</p>
					<p>Siempre, ante sospecha de síndrome de abstinencia de opioides, solicitar apoyo activo del servicio de Clínica del Dolor y de los servicios de Psicología y Psiquiatría de la institución.</p>
					<p>En pacientes manejados con opioides fuertes parenterales en Unidad de Quemados (Unidad Intermedia) o Unidad de</p>
					<p>Cuidados Intensivos, sospechar abstinencia de opioides ante síntomas sugestivos (taquicardia, diaforesis, hipertensión, midriasis, piloerección, calambres musculares, calambres abdominales, diarrea), sugiriéndose destete de opioides fuertes, si se han usado por más de 5 días, disminuyendo inicialmente un 20 - 40% la dosis, y posteriormente reducciones subsecuentes de 10% cada 12 - 24 horas.<xref ref-type="bibr" rid="B51"><sup>51</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B54"><sup>54</sup></xref>
					</p> <p>Ante hallazgos físicos de abstinencia de opioides, y con uso de opioides fuertes por más de 10 días, considerar inicio de terapia sustitutiva con metadona a dosis equianalgésica fraccionada cada 6 - 8 horas, y disminuyendo el 20% de dicha dosis semanalmente hasta suspensión completa hacia la 5ta semana.<xref ref-type="bibr" rid="B51"><sup>51</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B55"><sup>55</sup></xref>
					</p> <p>Se sugiere el uso de terapia no sustitutiva (Benzodiacepinas, Clonidina), concomitantemente con terapia sustitutiva.<xref ref-type="bibr" rid="B54"><sup>54</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B56"><sup>56</sup></xref>
					</p> </sec>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusiones</title>
				<p>El manejo de dolor en el paciente quemado constituye un desafío debido al enfoque multidisciplinario que idealmente debe recibir. Entender la fisiopatología de las lesiones por quemadura es fundamental para entender los tipos de dolor que suelen presentar estos pacientes y la severidad de los mismos. El manejo agudo del dolor no se debe centrar solamente en los componentes somáticos del mismo, sino que debe extenderse a los componentes emocionales y psicosociales, para brindar un manejo integral, tanto farmacológico como no farmacológico.</p>
			</sec>
			<sec>
				<title>Responsabilidades éticas</title>
				<p><bold>
 <italic>Protección de personas y animals.</italic> 
</bold> Los autores declaran que para esta investigación no se han realizado experimentos en seres humanos ni en animales.</p>
				<p><bold>
 <italic>Confidencialidad de los datos.</italic> 
</bold> Los autores declaran que han seguido los protocolos de su centro de trabajo sobre la publicación de datos de pacientes.</p>
				<p><bold>
 <italic>Derecho a la privacidad y consentimiento informado.</italic> 
</bold> Los autores declaran que en este artículo no aparecen datos de pacientes.</p>
			</sec>
			<sec>
				<title>Financión</title>
				<p>Los autores declaran no haber recibido financiación externa.</p>
			</sec>
			<sec>
				<title>Conflicto de intereses</title>
				<p>Los autores declaran que no existe conflicto de intereses.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="other" id="fn4">
					<label>Cómo citar este artículo:</label>
					<p> Cáceres-Jerez LE, Gomezese-Ribero OF, Reyes-Cárdenas LI, Vera-Campos JA, Guzmán-Rueda VA, Azar-Villalobos JP, Meléndez-Flórez HJ. Manejo del dolor agudo en el paciente gran quemado: Revisión no sistemática de la literatura. Rev Colomb Anestesiol. 2018;46:52-57.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article-->
</article>